Skip to content

The sub-chronic effects of coffee on cognitive function in a healthy older population

The sub-chronic effects of coffee on cognitive function in a healthy older population

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609001025224
Enrollment
121
Registered
2009-11-25
Start date
2009-11-10
Completion date
2010-11-05
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study is being conducted to see the sub-chronic effects of various coffee beverages on cognition, cardiovascular function and mood in healthy older adults. The study will compare the effect of different types of instant coffee beverages. Participants will consume one of four types of coffee beverages daily for 3 months. We will measure performance on different cognitive tasks, mood and cardiovascular measures before the consumption of the coffee beverage (baseline), 1-month after consumption of the coffee beverage and 3-months after consumption of the coffee beverage.

Interventions

Participants consume 3 servings of coffee per day for 3 months. Participants will be allocated to one of four types of instant coffee beverages (including one placebo beverage) with varying levels of caffeine in a between-subject, counter-balanced design. Each beverage is 3 g coffee mixed with boiling water and milk if desired.

Sponsors

Brain Sciences Institute, Swinburne University of
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Aged 60 and over Medically and psychiatrically healthy Light to moderate coffee drinkers Ability to provide written informed consent

Exclusion criteria

Currently taking psychotropic medications, existing psychiatric and neurological conditions, smoker, clinically high blood pressure, allergy to lactose, gluten or wheat

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026